T cells from indolent CLL patients prevent apoptosis of leukemic B cells in vitro and have altered gene expression profile

Cancer Immunology, Immunotherapy

Volumn 62, Issue 1, 2013, Pages 51-63

  Kiaii, Shahryar ^b,e   Kokhaei, Parviz ^c,e   Mozaffari, Fariba ^e   Rossmann, Eva ^a   Pak, Fatemeh ^c,e   Moshfegh, Ali ^e   Palma, Marzia ^a   Hansson, Lotta ^a   Mashayekhi, Kaveh ^a   Hojjat Farsangi, Mohammad ^e   Österborg, Anders ^a   Choudhury, Aniruddha ^d,e   Mellstedt, Håkan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d GREENSLOPES PRIVATE HOSPITAL   (Australia)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Apoptosis; CLL; Gene array; T cell

Indexed keywords

CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; INTERLEUKIN 4; KRUPPEL LIKE FACTOR 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;

ADULT; AGED; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CANCER IMMUNOLOGY; CCL4 GENE; CCL5 GENE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CONTACT; CELL EXPANSION; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; KLF6 GENE; LYMPHOCYTE FUNCTION; MALE; MULTIPLE MYELOMA; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TRAF1 GENE; UPREGULATION; XCL1 GENE; XCL2 GENE;

AGED; AGED, 80 AND OVER; APOPTOSIS; B-LYMPHOCYTES; COCULTURE TECHNIQUES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TRANSCRIPTOME;

EID: 84872500047     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-012-1300-y     Document Type: Article

References (48)

1. Bo MD, Bomben R, Zucchetto A et al (2012) Microenvironmental interactions in chronic lymphocytic leukemia: hints for pathogenesis and identification of targets for rational therapy. Curr Pharm Des. pii:CPD-EPUB-20120510-1
2. Chiorazzi N, Rai KR, Ferrarini M (2005) Chronic lymphocytic leukemia. N Engl J Med 352(8):804-815
3. Ghia P, Caligaris-Cappio F (2006) The origin of B-cell chronic lymphocytic leukemia. Semin Oncol 33(2):150-156
4. Kiaii S, Choudhury A, Mozaffari F et al (2005) Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia (B-CLL): comparison of indolent and progressive disease. Med Oncol 22(3):291-302
5. Mellstedt H, Choudhury A (2006) T and B cells in B-chronic lymphocytic leukaemia: faust, mephistopheles and the pact with the devil. Cancer Immunol Immunother 55(2):210-220
6. Mellstedt H, Pettersson D (1974) Lymphocyte subpopulations in chronic lymphocytic leukemia. Characterization by cell surface markers, cytotoxic activity, and mitogenic stimulation. Scand J Immunol 3(3):303-310
7. Scrivener S, Goddard RV, Kaminski ER et al (2003) Abnormal T-cell function in B-cell chronic lymphocytic leukaemia. Leuk Lymphoma 44(3):383-389
8. Kiaii S, Choudhury A, Mozaffari F et al (2006) Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia: long-term effects of fludarabine and alemtuzumab treatment. Leuk Lymphoma 47(7):1229-1238. doi: 10.1080/10428190600565503
9. Palma M, Kokhaei P, Lundin J et al (2006) The biology and treatment of chronic lymphocytic leukemia. Ann Oncol 17(Suppl 10):x144-x154
10. Rossmann ED, Lewin N, Jeddi-Tehrani M et al (2002) Intracellular T cell cytokines in patients with B cell chronic lymphocytic leukaemia (B-CLL). Eur J Haematol 68(5):299-306
11. Ghia P, Caligaris-Cappio F (2000) The indispensable role of microenvironment in the natural history of low-grade B-cell neoplasms. Adv Cancer Res 79:157-173
12. Ghia P, Circosta P, Scielzo C et al (2005) Differential effects on CLL cell survival exerted by different microenvironmental elements. Curr Top Microbiol Immunol 294:135-145
13. Ghia P, Strola G, Granziero L et al (2002) Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22. Eur J Immunol 32(5):1403-1413
14. Granziero L, Circosta P, Scielzo C et al (2003) CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes. Blood 101(5):1962-1969
15. Cheson BD, Bennett JM, Grever M et al (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87(12):4990-4997
16. Boyum A (1977) Separation of lymphocytes, lymphocyte subgroups and monocytes: a review. Lymphology 10(2):71-76
17. Ni H, Ergin M, Tibudan SS et al (2003) Protein kinase C-delta is commonly expressed in multiple myeloma cells and its downregulation by rottlerin causes apoptosis. Br J Haematol 121(6):849-856
18. Kokhaei P, Palma M, Hansson L et al (2007) Telomerase (hTERT 611-626) serves as a tumor antigen in B-cell chronic lymphocytic leukemia and generates spontaneously antileukemic, cytotoxic T cells. Exp Hematol 35(2):297-304. doi: 10.1016/j.exphem.2006.10.006
19. Plander M, Seegers S, Ugocsai P et al (2009) Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles. Leukemia 23(11):2118-2128. doi: 10.1038/leu.2009.145
20. Plander M, Ugocsai P, Seegers S et al (2011) Chronic lymphocytic leukemia cells induce anti-apoptotic effects of bone marrow stroma. Ann Hematol 90(12):1381-1390. doi: 10.1007/s00277-011-1218-z
21. Gorgun G, Holderried TA, Zahrieh D et al (2005) Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells. J Clin Invest 115(7):1797-1805
22. Nishio M, Endo T, Tsukada N et al (2005) Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha. Blood 106(3):1012-1020
23. Kurtova AV, Balakrishnan K, Chen R et al (2009) Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance. Blood 114(20):4441-4450. doi: 10.1182/blood-2009-07-233718
24. Mohle R, Failenschmid C, Bautz F et al (1999) Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1). Leukemia 13(12):1954-1959
25. Pedersen IM, Kitada S, Leoni LM et al (2002) Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1. Blood 100(5):1795-1801
26. Tinhofer I, Weiss L, Gassner F et al (2009) Difference in the relative distribution of CD4+ T-cell subsets in B-CLL with mutated and unmutated immunoglobulin (Ig) VH genes: implication for the course of disease. J Immunother 32(3):302-309. doi: 10.1097/CJI.0b013e318197b5e4
27. Gamberale R, Geffner J, Arrosagaray G et al (2001) Non-malignant leukocytes delay spontaneous B-CLL cell apoptosis. Leukemia 15(12):1860-1867
28. Lundin J, Kimby E, Bergmann L et al (2001) Interleukin 4 therapy for patients with chronic lymphocytic leukaemia: a phase I/II study. Br J Haematol 112(1):155-160. pii:bjh2525
29. Machura E, Mazur B, Rusek-Zychma M et al (2010) Cytokine production by peripheral blood CD4+ and CD8+ T cells in atopic childhood asthma. Clin Dev Immunol 2010:606139. doi: 10.1155/2010/606139
30. Coscia M, Pantaleoni F, Riganti C et al (2011) IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells. Leukemia 25(5):828-837. doi: 10.1038/leu.2011.12
31. Bagnara D, Kaufman MS, Calissano C et al (2011) A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease. Blood 117(20):5463-5472. doi: 10.1182/blood-2010-12-324210
32. Colombara M, Antonini V, Riviera AP et al (2005) Constitutive activation of p38 and ERK1/2 MAPKs in epithelial cells of myasthenic thymus leads to IL-6 and RANTES overexpression: effects on survival and migration of peripheral T and B cells. J Immunol 175(10):7021-7028. pii:175/10/7021
33. Ek S, Bjorck E, Hogerkorp CM et al (2006) Mantle cell lymphomas acquire increased expression of CCL4, CCL5 and 4-1BB-L implicated in cell survival. Int J Cancer 118(8):2092-2097. doi: 10.1002/ijc.21579
34. Walunas TL, Lenschow DJ, Bakker CY et al (1994) CTLA-4 can function as a negative regulator of T cell activation. Immunity 1(5):405-413
35. Guan E, Wang J, Roderiquez G et al (2002) Natural truncation of the chemokine MIP-1 beta/CCL4 affects receptor specificity but not anti-HIV-1 activity. J Biol Chem 277(35):32348-32352. doi: 10.1074/jbc.M203077200
36. Billard C, Kern C, Tang R et al (2003) Flavopiridol downregulates the expression of both the inducible NO synthase and p27(kip1) in malignant cells from B-cell chronic lymphocytic leukemia. Leukemia 17(12):2435-2443
37. Levesque MC, Misukonis MA, O'Loughlin CW et al (2003) IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells. Leukemia 17(2):442-450
38. Zhao H, Dugas N, Mathiot C et al (1998) B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity. Blood 92(3):1031-1043
39. Nabeshima S, Nomoto M, Matsuzaki G et al (1999) T-cell hyporesponsiveness induced by activated macrophages through nitric oxide production in mice infected with Mycobacterium tuberculosis. Infect Immun 67(7):3221-3226
40. van der Veen RC (2001) Nitric oxide and T helper cell immunity. Int Immunopharmacol 1(8):1491-1500
41. Zapata JM, Krajewska M, Morse HC III et al (2004) TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice. Proc Natl Acad Sci USA 101(47):16600-16605. doi: 10.1073/pnas.0407541101
42. Huang H, Li F, Cairns CM et al (2001) Neutrophils and B cells express XCR1 receptor and chemotactically respond to lymphotactin. Biochem Biophys Res Commun 281(2):378-382. doi: 10.1006/bbrc.2001.4363
43. Kabouridis PS (2006) Lipid rafts in T cell receptor signalling. Mol Membr Biol 23(1):49-57. doi: 10.1080/09687860500453673
44. Rajendran L, Simons K (2005) Lipid rafts and membrane dynamics. J Cell Sci 118(Pt 6):1099-1102. doi: 10.1242/jcs.01681
45. Razzaq TM, Ozegbe P, Jury EC et al (2004) Regulation of T-cell receptor signalling by membrane microdomains. Immunology 113(4):413-426
46. Bromley SK, Burack WR, Johnson KG et al (2001) The immunological synapse. Annu Rev Immunol 19:375-396. pii:19/1/375
47. Stinchcombe JC, Bossi G, Booth S et al (2001) The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity 15(5):751-761
48. Waugh SM, Harris JL, Fletterick R et al (2000) The structure of the pro-apoptotic protease granzyme B reveals the molecular determinants of its specificity. Nat Struct Biol 7(9):762-765. doi: 10.1038/78992